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Immunoimaging scanning probe microscopy was utilized for the low-level detection and quantiﬁcation of biotinylated G4
poly(amidoamine) PAMAM dendrimers. Results were compared to those of high-performance liquid chromatography (HPLC)
and found to provide a vastly improved analytical method for the low-level detection of dendrimers, improving the limit of
detectionbyafactorof1000(LOD = 2.5×10
−13 moles).Thebiorecognitionmethodisreproducibleandshowshighspeciﬁcityand
good accuracy. In addition, the capture assay platform shows a promising approach to patterning dendrimers for nanotechnology
applications.
1.Introduction
Dendrimers are at the forefront of research in nanoscience
due to the many interesting properties of these macro-
molecular systems including their precise architecture,
highly reproducible shape, high uniformity and purity, low
immunogenicity and toxicity, high loading capacity, and
high shear resistance [1–5]. They have shown a great deal
of versatility with applications in numerous areas such as
drug delivery [6, 7], gene therapy [8, 9], chemotherapy
[10], electrochemistry [11, 12], metal recovery [13], catalysis
[14, 15], and sensors [16–18]. Development of new low-level
detection and quantiﬁcation methods is needed with the uti-
lizationofthesenanomaterials.Currently,high-performance
liquidchromatography(HPLC)isthepredominateapproach
reported for dendrimer quantiﬁcation [19, 20]. However, the
primary focus of HPLC, along with capillary electrophoresis,
has been to evaluate dendrimer purity and degree of conju-
gation [21–27]. Little has been reported within the literature
with regard to the advancement of new quantiﬁcation
methods for dendrimers.
Thisworkintroducesabiorecognitionreadouttechnique
that has the potential to provide low-level detection of
dendrimers. Biotinylated poly(amidoamine) PAMAM den-
drimers were chosen as a model target. PAMAM dendrimers,
which are highly water soluble, represent the most widely
studied class of dendrimers. Functionalization of PAMAM
dendrimer surfaces has proven useful in their utilization for
various applications including drug delivery and chemical
sensing [5, 6, 16]. Biotin-labeled dendrimers have been
utilized in tumor [28]a n da n t i b o d y[ 29] targeting studies
and biosensor design [30]. Biotinylated PAMAM dendrimers
may also have the potential for delivering therapeutic drugs
to the brain [31, 32].
We report here a readout method using an immunoassay
platform and scanning probe microscopy (SPM) for low-
level quantiﬁcation of biotinylated G4 PAMAM dendrimers.
The assay takes advantage of the documented speciﬁcity of
biotin-avidin. Results are correlated with HPLC analysis. In
addition, we brieﬂy highlight the potential of this capture
assay platform to selectively pattern PAMAM dendrimers
onto a surface. Patterning of nanoparticles is relevant to a
wide variety of applications in the ﬁelds of sensing, drug
delivery, or development of nanodevices [33–35]. Dendritic
architectures show promise in designing and developing
sensor platforms with high sensitivity and stability [16].2 International Journal of Analytical Chemistry
2. Experimental
2.1. Reagents. Poly(amidoamine) PAMAM dendrimers
[core: ethylene diamine] (G = 4) dendri-PAMAM-(NH2)32
were obtained from Dendritic Nanotechnologies, Inc. (Mt.
Pleasant, MI). Biotinylated PAMAM dendrimers were
prepared using sulfo-NHS-LC-biotin (Pierce EZ-Link Kit)
as described previously [36] .B r i e ﬂ y ,a3 : 1m o l a rr a t i oo f
biotin/PAMAM dendrimers in 0.1M phosphate buﬀer saline
(PBS) was allowed to react for 2h on an orbital shaker.
Excess, unreacted biotin was then removed using Microcon
ﬁlters (Millipore. Bedford, MA, USA). The biotinylation
of dendrimers was evaluated using NMR spectroscopy.
Biotinylated dendrimers were resuspended (1.0mg/mL)
in 1.0M PBS until used. Octadecanethiol (ODT), 3,3 -
dithio-bis(propionic acid N-hydroxysuccinimide ester)
(DSP), bovine serum albumin (BSA), Triton X-100, and
avidin >98% were obtained from Sigma (Sigma-Aldrich,
St. Louis, MO). Avidin conjugated to Alexa Fluor 488 was
purchased from Invitrogen (Invitrogen, Carlsbad, CA).
Poly(dimethyl siloxane) (PDMS) was obtained from Dow
Corning (Midland, MI). All organic solvents used were
analytical, HPLC grade, from Sigma (Sigma-Aldrich, St.
Louis, MO). DI water was obtained using a Milli-Q plus
water puriﬁcation system (Millipore, Bedford, MA). PBS
and Borate buﬀers were prepared from Pierce buﬀer packs
(Pierce Protein Research Products, Rockford, IL).
2.2. Capture Substrate Preparation. A modiﬁed approach
was used for preparation of the capture substrate [37–39]
utilizing template-stripped gold (TSG) for SPM imaging, as
shown in Figure 1. TSG was prepared by evaporating gold
onto p-type silicon wafers (University Wafer) with a resistive
evaporator and aﬃxing 1 × 1cm glass pieces (ultrasonically
cleaned 30min each in diluted Contrad 70, DI water,
and methanol) using two-part epoxy (Epoxy Technology)
followed by curing at 150◦C for 2h. The glass pieces were
gently detached from the silicon wafer revealing a smooth
gold surface atop the glass chip.
The TSG substrates were exposed for ∼30s to an ODT
soaked PDMS stamp (with a 3mm diameter hole cut in
the center), rinsed with ethanol, and dried under high-
purity nitrogen. The substrates were then placed in a 0.1mM
solution of DSP in ethanol overnight. The capture platform
was then rinsed with ethanol and dried under N2. This
formed the DSP-based adlayer in the areas on the substrate
not covered by ODT. The hydrophobic ODT localized
reagents in a conﬁned sample area (3mm ODT spot size) for
the capture assay platform.
To form the capture avidin surface, a 20μLa l i q u o to f
avidin solution (500μg/mL diluted in 50mM borate buﬀer)
was placed on top of the sample area and allowed to
incubatefor6hatroomtemperatureinahumidity chamber.
Substrates were then rinsed with 5mL of 10mM PBS (with
0.1% Triton X-100), and the surface area was incubated
with a 20μL solution of blocking buﬀer (1% (w/v) BSA in
20mM borate buﬀer with 0.1% Triton X) for 5h, followed
by rinsing with 5mL of 10mM PBS. The capture substrate
was then exposed to 20μL aliquots of various concentrations
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Figure 1: Schematic of capture assay platform: (a) immobilize
avidin onto Au substrate with controlled surface area using DSP
and (b) expose substrate to biotinylated PAMAM dendrimers. (c)
ThecapturedbiotinylatedPAMAMdendrimerscanbeﬂuorescently
labeled for additional veriﬁcation of immobilization and patterning
of dendrimers.
of biotinylated G4 PAMAM dendrimers diluted in 10mM
PBS for 8h at room temperature in a humidity chamber.
Substrates were then rinsed with 5mL of 10mM borate
buﬀer before drying with nitrogen. A blank sample consisted
of all stages except the avidin capture surface.
To demonstrate patterning of biotinylated G4 PAMAM
dendrimers, a PDMS stamp with a positive structure of
10μm wide stripes separated by 5μm was utilized. Prepa-
ration of the patterned substrate consisted of all stages,
with the following modiﬁcations: (1) a sample volume of
200μL was used instead of 20μL and (2) after incubation
with biotinylated G4 PAMAM dendrimers, the substrate
was rinsed with 10mM PBS and the dendrimers were
ﬂuorescently tagged by incubating the substrate with 200μL
of 250ug/mL of Alexa Fluor conjugated avidin. Following
this step the substrates were rinsed with 5mL of 10mM
borate buﬀer and dried with nitrogen.
2.3. Scanning Probe Microscopy. A Dimension 3100 Digital
Instruments SPM was utilized in tapping mode equipped
with 125μm n-doped silicon cantilevers with resonance
frequencies between 110 and 220kHz and typical scan ratesInternational Journal of Analytical Chemistry 3
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Figure 2:RepresentativeSPMimagesofcapturesurface(1×1μm)ofdiﬀerentconcentrationsofboundbiotinylatedG4PAMAMdendrimers
to avidin capture substrate: (a) blank and (b) 7.0 × 10
−3 μmol/L, (c) 7.0 × 10
−2 μmol/L, and (d) 3.28 × 10
−1 μmol/L; (e) a cross-sectional
analysis of captured biotinylated G4 PAMAM dendrimers in (d).
of 0.75–1Hz (NSC 14, MikroMasch). Typical scan rates were
1Hz, and all images were acquired in air. For quantiﬁcation,
multiple areas of the capture surface were analyzed and
the dendrimers in each 1 × 1μm image were enumerated
manually.
2.4. High-Performance Liquid Chromatography. HPLC anal-
ysis of G4 biotinylated PAMAM dendrimers was conducted
usingparametersreportedpreviously[36].Brieﬂy,areversed
phase HPLC system consisting of a Waters Breeze HPLC
(Waters Corporation, Milford, MA, USA), equipped with
a 717plus autosampler, 2487 dual λ UV detector, 5μm
Symmetry300C18column(4.6mm×150mm),andaWaters
Sentry Symmetry C18 guard column was used. The mobile
phase consisted of a linear gradient beginning with 90%
water and 10% ACN (each with 0.14% TFA) at a ﬂow4 International Journal of Analytical Chemistry
rate of 1mL/min reaching 68% water and 32% ACN over
10minutes. The injection volume was 100μL, and detection
of eluted samples was performed at 214nm.
2.5. Fluorescent Microscopy. A Nikon E600 ﬂuorescent
microscope with a Mercury-100W light source was utilized
to take images at 100x total magniﬁcation.
3. Results andDiscussion
The principle goal of this work was the development
and application of capture platform for quantiﬁcation of
PAMAM dendrimers. A model assay was evaluated using
biotinylated G4 PAMAM dendrimers and avidin. Avidin
was immobilized onto a patterned thiolate layer, DSP, via
succinimidyl ester chemistry (Figure 1). In the presence
of biotinylated G4 PAMAM dendrimers, the immobilized
avidin layer extracts the dendrimers. SPM analysis of the
capture platform revealed the presence of nanometrically
sized objects, ∼4.5nm in dimension, according to cross-
sectional height proﬁles. These are consistent in size and
shape of G4 biotinylated PAMAM dendrimers, taking into
account tip convolution eﬀects (Figure 2). At this scale, the
tip convolution eﬀects distorted the resolution in the lateral
dimensions, as the dimensions of the particles are smaller
thantheradiusofcurvatureoftheAFMprobeused(radius =
20nm) [40, 41]. The dendrimers largely appear to be
captured individually on the platform surface. In some cases
dendrimers were found grouped together (2-3 dendrimer
clusters) but could be individually distinguished using cross-
sectional analysis. SPM analysis reveals that the dendrimers
do not have a tendency to cluster together in domains,
indicating that sedimentation is not a factor during the
incubation. Analysis of control (blank) substrates, devoid of
theavidin-speciﬁccapturesurface,showslimitednonspeciﬁc
binding (0.67 ± 0.45 dendrimers/μm2) and that blocking
steps are eﬀective.
The patterning of DSP provides a reproducible surface
area for quantiﬁcation. Figure 2 shows that the number
of captured G4 biotinylated PAMAM dendrimers tracks
with the increase in dendrimer solution concentration. The
degree of bound dendrimers was similar for various diﬀerent
areas of the capture surface. A calibration plot of the
amount of captured G4 biotinylated PAMAM dendrimers
(determined by SPM analysis) as a function of solution
concentration is shown in Figure 3(a).T h en u m b e ro fc a p -
tured dendrimers correlates with G4 biotinylated PAMAM
dendrimer concentrations, showing a linear dynamic range
undertheconcentrationsrangeevaluated(7.0 ×10
−3–3.28 ×
10
−1μmol/L). This readout method has the potential for
low limits of detection. The limit of detection can be
estimated as the signal three times above the measurement
noise, where the noise is the sample blank response. This
corresponds to a limit of detection of ∼2.5 × 10−13 moles.
Results were correlated with a standard HPLC analysis
approach for quantiﬁcation of dendrimers, as shown in
Figure 3(b). HPLC quantiﬁcation of dendrimers shows a
linear dynamic range under the concentrations evaluated
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Figure 3: Calibration curves for (a) immunoimaging SPM assay
and(b)HPLCanalysisofG4biotinylatedPAMAMdendrimers.The
SPM analysis represents the average number of dendrimers bound
within a 1 × 1μma r e af o rd i ﬀerent concentrations of dendrimers.
Data acquired from 10 capture substrates, with 10 images per
sample (y = 58.1x +1 .76, n = 20, r2 = 0.9964). The HPLC
analysis represents an average of 10 samples for each concentration
evaluated (y = 34620.85x + 28845.984, n = 10, r2 = 0.9986).
(7.0 × 10
−1–70.35μmol/L) with a corresponding limit of
detection of 1.8 × 10
−10 moles. The capture assay platform
improves the limit of detection by a factor of 1000. It should
also be noted that the concentrations investigated by the
capture assay were not detectable by HPLC analysis.
The capture assay platform has shown the potential for
low-level detection and quantiﬁcation of G4 biotinylated
PAMAM dendrimers. Further improvements in the perfor-
mance of this immunosorbent assay approach such as the
reduction of incubation times may be possible by utilizing
a rotating capture substrate to increase the ﬂux of analyte to
the capture surface [38]. In addition, the limit of detection
may be further improved by reducing the area dimensionInternational Journal of Analytical Chemistry 5
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Figure 4: SPM image of capture surface patterning: (a) height and (b) phase (8 × 8μm), zoomed in analysis; (c) height and (b) phase of
capture stripe (avidin immobilized on DSP) containing bound G4 biotinylated PAMAM dendrimers. Cross-section analysis of bound G4
biotinylated PAMAM dendrimers in (d) is shown in (e). The capture platform was exposed to 200μLo f5 . 0μmol/L concentration of G4
biotinylated PAMAM dendrimer solution.
of the DSP capture platform. The range of dendrimers that
can be quantiﬁed using this approach is potentially limited
to the analyte capture surface and labeling strategy of the
dendrimers. This quantiﬁcation method can be applied to
any type of immunosorbant assay approach (e.g., antibody
antigen binding). In addition, the capture platform design
couldbeutilizedformultidetectioncapability.Itisimportant
to note, however, that quantiﬁcation of unfunctionalized
dendrimers would require a labeling strategy for this capture
assay approach to be used.
The capture assay platform also has the ability to selec-
tively pattern PAMAM dendrimers onto a surface, as shown
in Figure 4. In this study a PDMS stamp with a positive
structure of 10μm wide stripes separated by 5μms tri p e sw a s
used to pattern G4 biotinylated PAMAM dendrimers using
the assay approach. Figures 4(a) and 4(b) show the height
andphaseanalysisofthepatternedsurface.Thebrightstripes
in the height analysis (Figure 4(a)) correspond to the ODT
layer (10μm wide), and the darker stripe corresponds to
the DSP layer (5μm wide). The height diﬀerence (∼2.5nm)6 International Journal of Analytical Chemistry
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Figure 5: Fluorescence image of capture surface assay utilizing
Alexa Fluor conjugated avidin: (a) blank and (b) G4 biotinylated
PAMAM dendrimers bound to avidin capture substrate.
is consistent with the diﬀering dimensions of ODT and
DSP monolayers. It can be seen from the phase analysis
that the captured dendrimers are more easily identiﬁable
in the DSP stripe (Figure 4(b)). Figures 4(c) and 4(d)
present higher-resolution height and phase analysis of the
patterned G4 biotinylated PAMAM dendrimers. In these
SPM images the individual dendrimers bound to the DSP
stripe can be ascertained. The dendrimers are individually
distributed within the DSP stripe. The dendrimers do not
clump together and multilayers of dendrimers are not
evident. Furthermore, the ODT layers do not show any
evidence of nonspeciﬁc adsorption. Cross-sectional height
proﬁles (∼4.5nm) are consistent with G4 dendrimers. The
slight variabilities in the height may be due to variations
in how the biotin on the dendrimer surface is bound
to the avidin capture platform. Further validation of the
patterning of the G4 biotinylated PAMAM dendrimers was
conducted by tagging the bound dendrimers with Alexa
Fluor conjugated avidin, as shown in Figure 5.F l u o r e s c e n c e
imaging veriﬁes that the dendrimers are patterned on the
avidin capture surface over large surface areas. Analysis
of the blank conﬁrms that nonspeciﬁc adsorption of G4
biotinylated PAMAM dendrimers is minimal. The bound
patterned dendrimers have been found to be stable on
the capture platform for >1 year under ambient storage
conditions. Although, methods such as direct microcontact
printing [42] dip-pen lithography [43], and electron-beam
patterning[44]ofdendrimershavebeenreportedpreviously,
they do not provide the selective patterning of this approach.
Thedimensionsandproﬁlesofthepatterneddendrimerscan
be modiﬁed using diﬀerent PDMS platforms.
4. Conclusions
This paper has demonstrated the potential value of immun-
oimaging SPM to detect and quantify G4 biotinylated
PAMAM dendrimers. Results were presented that showed
that this new approach using an immunoassay platform
provides a 1000-fold improvement in the limit of detection
of dendrimers compared to current quantiﬁcation meth-
ods using HPLC. The range of dendrimers that could
be evaluated with this approach is potentially limited to
the availability of analyte capture and labeling strategies.
Findings have also shown the potential of this platform to
pattern dendrimers for sensor and nanodevice applications.
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